Marco Gambarotti, MD

Photo Marco Gambarotti, MD
Marco Gambarotti, MD

Personal information - Education and work experience


Head of the structure "Anatomy and pathological histology".

Degree in Medicine and Surgery, with honors.

Specialization in Anatomic Pathology, with honors.

Researcher at the University of Brescia from April 2007 to May 2008 (title of the project: "Evaluation and improvement about the pathologic activity in liver diseases").
Since May 2008 pathologist in the Pathology Department of the Rizzoli Orthopaedic Institute in Bologna. He has diagnosed more than 15.000 cases of soft tissue and bone pathology. He worked under the direction of dr. Marco Alberghini until June 2012. He is working with the advice of Prof. Franco Bertoni, Dr. Angelo Paolo Dei Tos, dr. Piero Picci, and Prof. Daniel Vanel (consultant radiologist of the Rizzoli Orthopedic Institute).

Fluent English.

Good skills in using Office Applications, Internet programs, programs for histological reports, Photoshop and other programs for the management of gross and microscopic pictures.

Educational training of Italian and foreign visitors who regularly visit the Pathology Department of the Rizzoli Orthopedic Institute.
Teacher of Anatomic Pathology at the School of Specialization in Rheumatology (University of Bologna).

Author and co-author of scientific papers on National or International Journals.
Co-author of the “Atlas of Musculoskeletal Tumors and Tumorlike Lesions - The Rizzoli Case Archive”.
Participation in many courses about Anatomic Pathology and Musculoskeletal Oncology. In particular he is co-organizator and speaker in the annual “Joint IOR/MSKCC Course on Musculoskeletal Pathology” of the Rizzoli Orthopedic Institute.
Member of the ISG (Italian Sarcoma Group).

Collaboration in national and European projects on bone and soft tissue tumors.
Organization and management of the Rizzoli Orthopedic Institute’s Biobank in the National Network of the Biobanks.
He is implied in the following experimental protocols of the ISG (Italian Sarcoma Group):

  • Expression of ABCB1/Pglycoprotein as a prognostic factor for non-metastatic osteosarcoma of the extremities: prospective study (ISG/OS-2). In this study the Pathology Department of the Rizzoli Orthopedic Institute is the referring center for the evaluation of the expression of ABCB1/Pglycoprotein.
  • Integrated approach to a standard neoadjuvant "histotype-tailored" chemotherapy in localized high-risk soft tissue sarcomas (ISG-STS 10-01). In this study the Pathology Department of the Rizzoli Orthopedic Institute actively participates in the national protocol.
Content updated 29/03/2019 - 15:47
Utilizza SharethisShareThis  Scrivi una email  Vai a facebook  Vai a twitter